I
Italo Bearzi
Researcher at Marche Polytechnic University
Publications - 107
Citations - 4184
Italo Bearzi is an academic researcher from Marche Polytechnic University. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 33, co-authored 107 publications receiving 3958 citations.
Papers
More filters
Journal ArticleDOI
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease
Carlo Catassi,E Fabiani,Giuseppe Iacono,Cinzia D'Agate,Ruggiero Francavilla,Federico Biagi,Umberto Volta,Salvatore Accomando,Antonio Picarelli,Italo De Vitis,Giovanna Pianelli,Rosaria Gesuita,Flavia Carle,Alessandra Mandolesi,Italo Bearzi,Alessio Fasano +15 more
TL;DR: The ingestion of contaminating gluten should be kept lower than 50 mg/d in the treatment of CD, and no significant differences in the IEL count were found between the 3 groups.
Journal ArticleDOI
Association of celiac disease and intestinal lymphomas and other cancers
TL;DR: Enteropathy-associated T-cell lymphoma (EATL) is a rare form of high-grade, T- cell non-Hodgkin lymphoma of the upper small intestine that is specifically associated with Celiac disease.
Journal ArticleDOI
Why is coeliac disease endemic in the people of the Sahara
Carlo Catassi,IIse-Maria Ratsch,Lenora Gandolfi,Riccardo Pratesi,E Fabiani,Ramzi El Asmar,Maria Frijia,Italo Bearzi,Luciano Vizzoni +8 more
TL;DR: Intestinal biopsies in a subsample confirmed that AEA is a marker of coellac disease in people living in a developing country.
Journal ArticleDOI
Epidermal Growth Factor Receptor (EGFR) Status in Primary Colorectal Tumors Does Not Correlate With EGFR Expression in Related Metastatic Sites: Implications for Treatment With EGFR-Targeted Monoclonal Antibodies
Mario Scartozzi,Italo Bearzi,Rossana Berardi,Alessandra Mandolesi,Guidalberto Fabris,Stefano Cascinu +5 more
TL;DR: The results suggest that the detection of the EGFR in primary colorectal cancer could be inadequate for planning therapy with EGFR-targeted monoclonal antibodies in a considerable proportion of both EG FR-positive and -negative primary tumors.
Journal ArticleDOI
Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy
Mario Scartozzi,Italo Bearzi,Chiara Pierantoni,Alessandra Mandolesi,Fotios Loupakis,Alberto Zaniboni,Vincenzo Catalano,Antonello Quadri,Fausto Zorzi,Rossana Berardi,Tommasina Biscotti,Roberto Labianca,Alfredo Falcone,Stefano Cascinu +13 more
TL;DR: The difference in median TTP, overall survival, and response rate seem to confirm that NF-kB may play a crucial role in predicting the efficacy of cetuximab and irinotecan in advanced colorectal tumors.